A zero-revenue public company tried to copy Michael Saylor to avoid delisting, but its stock immediately crashed 25%August 28, 2026
Serena Saggini received Prestigious Industry Recognition at Pharma X Next Conference 2026 Events & Conferences June 8, 2026 The Pharma X Next Conference 2026 is proud to welcome Serena Saggini, Director at Sophos Biotech S.r.l., Italy, as a…